IL10 and cancer: Also, a recent report [22] has suggested that polymorphisms associated with low expression of anti-inflammatory IL-10 and TGF-β1 and immunomodulatory TNF-α, IFN-γ and IL-6 could be involved in the mechanisms of cancer progression and escape from immune surveillance.